Aesthetic Medicine Market Size & Share 2026 - 2035
Market Size by Type, by Product, by Gender, by End Use – Global Forecast.
Download Free PDF
Market Size by Type, by Product, by Gender, by End Use – Global Forecast.
Download Free PDF
Starting at: $2,450
Base Year: 2025
Companies Profiled: 12
Tables & Figures: 341
Countries Covered: 19
Pages: 199
Download Free PDF
Aesthetic Medicine Market
Get a free sample of this report
Aesthetic Medicine Market Size
The global aesthetic medicine market was valued at USD 23.2 billion in 2025 and is projected to grow from USD 25.6 billion in 2026 to USD 80.2 billion by 2035, expanding at a CAGR of 13.5%, according to the latest report published by Global Market Insights Inc. This substantial growth is driven by numerous factors such as the increasing awareness regarding aesthetic procedures, technological advancements associated with medical aesthetic devices, rising prevalence of obesity, and increasing adoption of non-invasive procedures.
Aesthetic Medicine Market Key Takeaways
Market Size & Growth
Regional Dominance
Key Market Drivers
Challenges
Opportunity
Key Players
Aesthetic medicine is a part of healthcare that focuses on improving physical appearance through non-invasive or minimally invasive procedures. It seeks to address cosmetic issues like skin texture, wrinkles, pigmentation, body contouring, and hair restoration without major surgery. Common treatments include Botox, dermal fillers, chemical peels, laser therapy, and non-surgical fat reduction. Leading companies in the digital pathology field are Sisram Medical Ltd, Boston Scientific Corporation, Merz Pharma, Johnson & Johnson, and Bausch Health. These companies are expanding in the aesthetic medicine market by broadening their product lines, investing in research and development for new treatments, making strategic acquisitions, and growing their global presence through targeted marketing and entering emerging markets.
The market grew from USD 17.1 billion in 2022 to USD 21.1 billion in 2024. Greater awareness of aesthetic procedures drives growth in this market, as more people look for minimally invasive and surgical options to enhance their appearance and boost their confidence. According to the International Society of Aesthetic Plastic Surgery (ISAPS) 2024 report, around 38 million procedures took place worldwide, including 17.4 million surgical and 20.5 million non-surgical treatments, marking a 42.5% increase over the last four years. Popular surgical procedures, like eyelid surgery (2.1 million), liposuction (2.08 million), and breast augmentation (1.65 million), highlight the growing demand for cosmetic enhancements. This trend reflects greater social acceptance, technological progress, and improved accessibility, all of which contribute to the market's growth.
Additionally, the rising prevalence of obesity is becoming one of the most influential drivers of growth in the aesthetic medicine market, as millions of individuals seek effective solutions to improve body shape and appearance beyond traditional weight-loss methods. Obesity not only poses serious health risks but also impacts self-esteem and body image, prompting a surge in demand for procedures such as liposuction, tummy tucks, body contouring, and non-invasive fat reduction treatments.
According to the World Health Organization (WHO), more than 1 billion people worldwide were living with obesity in 2024, and obesity was linked to 3.7 million deaths globally; WHO warns that without stronger action, the number of people affected could double by 2030, potentially costing the world USD 3 trillion annually. As obesity rates climb, aesthetic clinics and device manufacturers are innovating with advanced technologies such as laser-assisted lipolysis, cryolipolysis, and radiofrequency-based treatments to meet growing consumer demand for safe, minimally invasive options. This alarming trend is fueling demand for aesthetic solutions that complement lifestyle changes, driving innovation and expansion in the global aesthetic medicine market.
Aesthetic Medicine, is a field of medicine that improves physical appreance using the combined techniques of surgical and non-surgical procedures to help to enhance the cosmetic value. The purpose of aesthetic medicine is to correct various issues such as wrinkles, scars, fat accumulation, skin laxity, cellulite, unwanted hair, and hyperpigmentation. This is accomplished using a variety of different methods both non-invasive and minimally invasive procedures as well as surgical procedures performed by trained medical professionals such as dermatologists, plastic surgeons, cosmetic surgeons and other appropriately qualified medical practitioners.
Aesthetic Medicine Market Trends
Aesthetic Medicine Market Analysis
Based on type, the market is bifurcated into non-surgical, and surgical. The surgical procedures segment was valued at USD 4.7 billion in 2025 and is expected to reach USD 16.6 billion by 2035.
Based on products, the aesthetic medicine market is divided into energy-based, and non energy-based products. The energy-based segment accounted for USD 5.6 billion in 2025.
Based on gender, the aesthetic medicine market is segmented into male, and female. The female segment held a market share of 84.6% in the year 2025.
Based on end use, the aesthetic medicine market is segmented into hospitals, ambulatory surgical centers, beauty centers and medical spas, dermatology clinics, and home settings. The hospitals segment held a market size of USD 7.7 billion in the year 2025.
North America Aesthetic Medicine Market
North America dominated the global market with a market share of 39.5% in 2025.
Europe Aesthetic Medicine Market
Europe market accounted for USD 6.8 billion in 2025 and is anticipated to show lucrative growth over the forecast period.
Germany aesthetic medicine market is projected to experience steady growth between 2026 and 2035.
Asia Pacific Aesthetic Medicine Market
The Asia Pacific region is projected to be valued at USD 5.1 billion in 2025.
Japan aesthetic medicine market is poised to witness lucrative growth between 2026 – 2035.
Latin America Aesthetic Medicine Market
Middle East and Africa Aesthetic Medicine Market
The aesthetic medicine market in Saudi Arabia is expected to experience significant and promising growth from 2026 to 2035.
Aesthetic Medicine Market Share
Aesthetic Medicine Market Companies
Few of the prominent players operating in the aesthetic medicine industry include:
Boston Scientific Corporation, a global leader in medical technology, has been expanding its portfolio through strategic acquisitions and innovation, primarily focusing on minimally invasive solutions. The company’s emphasis on R&D and integration of acquired technologies positions it to deliver safe, effective, and cutting-edge solutions for aesthetic treatments.
Bausch Health Companies Inc., through its global aesthetics division Solta Medical, is a prominent player in the aesthetic medicine market. Solta Medical offers innovative non-invasive skin tightening and resurfacing technologies, with Thermage FLX being one of its flagship products. With over 5 million Thermage treatments performed globally, Bausch Health continues to focus on expanding its reach and advancing proven technologies for facial and body rejuvenation.
Sisram Medical Ltd, a global leader in energy-based aesthetic solutions, is driving innovation through AI-powered platforms and personalized treatment offerings. By combining global R&D with localized strategies, Sisram is capitalizing on the rising demand for non-invasive procedures and personalized aesthetics, positioning itself as a frontrunner in the evolving aesthetic medicine landscape.
9.5% Market Share
Aesthetic Medicine Market News:
The aesthetic medicine market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million and from 2022 – 2035 for the following segments:
Click here to Buy Section of this Report
Market, By Type
Market, By Product
Market, By Gender
Market, By End Use
The above information is provided for the following regions and countries:
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →